UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancers after hematopoietic cell transplantation for aplastic anemia-the importance of persistence

Bone marrow transplantation (Basingstoke), 2022-02, Vol.57 (2), p.152-153

2022

Volltextzugriff (PDF)

Risk Score for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis

Cancer, 2009-10, Vol.115 (20), p.4715-4726

2009

Volltextzugriff (PDF)

Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases

Pediatric research, 2012-04, Vol.71 (4), p.439-444

2012

Volltextzugriff (PDF)

Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care—SAKK 33/99

Journal of clinical oncology, 2011-01, Vol.29 (3), p.303-309

2011

Volltextzugriff (PDF)

A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation

Blood, 2011-04, Vol.117 (17), p.4434-4441

2011

Volltextzugriff (PDF)

Does centre experience matter?

British journal of haematology, 2017-08, Vol.178 (4), p.497-498

2017

Volltextzugriff (PDF)

Similar outcome of upfront‐unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT

British journal of haematology, 2015-11, Vol.171 (4), p.585-594

2015

Volltextzugriff (PDF)

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups

Haematologica (Roma), 2012-08, Vol.97 (8), p.1142-1148

2012

Volltextzugriff (PDF)

Biomarkers in tumor angiogenesis and anti-angiogenic therapy

International Journal of Molecular Sciences, 2011-10, Vol.12 (10), p.7077-7099

2011

Volltextzugriff (PDF)

European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation

Leukemia, 2019-02, Vol.33 (2), p.508-517

2019

Volltextzugriff (PDF)

Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation

Blood, 2007-11, Vol.110 (9), p.3463-3471

2007

Volltextzugriff (PDF)

Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial

The lancet oncology, 2010-04, Vol.11 (4), p.331-338

2010

Volltextzugriff (PDF)

Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia

Leukemia research, 2017-07, Vol.58, p.43-47

2017

Volltextzugriff (PDF)

Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation

Annals of hematology, 2020-11, Vol.99 (11), p.2529-2538

2020

Volltextzugriff (PDF)

Leukemic blasts in transformed JAK2-V617F–positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation

Blood, 2007-07, Vol.110 (1), p.375-379

2007

Volltextzugriff (PDF)

Current approach for the diagnosis of Aplastic Anemia

Current drug targets, 2016-06, Vol.17 (999), p.1-1

2016

Volltextzugriff (PDF)

Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant

Second edition., 2021

Volltextzugriff (PDF)

Risk for Secondary Thyroid Carcinoma After Hematopoietic Stem-Cell Transplantation: An EBMT Late Effects Working Party Study

Journal of clinical oncology, 2007-06, Vol.25 (17), p.2449-2454

2007

Volltextzugriff (PDF)

Cardiovascular Complications in Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation

Seminars in hematology, 2012, Vol.49 (1), p.25-34

2012

Volltextzugriff (PDF)

Translational longevity medicine: a Swiss perspective in an ageing country

Swiss medical weekly, 2023-06, Vol.153 (6), p.40088

2023

Volltextzugriff (PDF)

Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria

Haematologica (Roma), 2012-11, Vol.97 (11), p.1666-1673

2012

Volltextzugriff (PDF)

Angiogenesis and vascular endothelial growth factor‐/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2‐V617F mutational status

British journal of haematology, 2009-07, Vol.146 (2), p.150-157

2009

Volltextzugriff (PDF)

Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma

Cytotherapy (Oxford, England), 2021-04, Vol.23 (4), p.329-338

2021

Volltextzugriff (PDF)

Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients

JAMA oncology, 2019-02, Vol.5 (2), p.229

2019

Volltextzugriff (PDF)

1 – 25 von 336

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(247)
Mit Volltextzugriff
(293)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(178)
Science & Technology
(178)
Humans
(175)
Hematology
(133)
Female
(100)
Adult
(96)
Male
(94)
Biological And Medical Sciences
(77)
Medical Sciences
(75)
Middle Aged
(75)
Adolescent
(53)
Aged
(52)
Child
(49)
Hematopoietic Stem Cell Transplantation
(48)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(45)
Hematologic And Hematopoietic Diseases
(44)
Transplantation
(35)
Retrospective Studies
(33)
Transplantation, Homologous
(32)
Oncology
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cancers after hematopoietic cell transplantation for aplastic anemia-the importance of persistence

Risk Score for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis

Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases

Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care—SAKK 33/99

A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation

Does centre experience matter?

Similar outcome of upfront‐unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups

Biomarkers in tumor angiogenesis and anti-angiogenic therapy

European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation

Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation

Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial

Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia

STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients

Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation

Leukemic blasts in transformed JAK2-V617F–positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation

Current approach for the diagnosis of Aplastic Anemia

Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant

Risk for Secondary Thyroid Carcinoma After Hematopoietic Stem-Cell Transplantation: An EBMT Late Effects Working Party Study

Cardiovascular Complications in Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation

Translational longevity medicine: a Swiss perspective in an ageing country

Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria

Angiogenesis and vascular endothelial growth factor‐/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2‐V617F mutational status

Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma

Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients

Suchergebnisse filtern